PYRIDOSTIGMINE PHARMACIE CENTRALE DES ARMEES 30 mg, tablet 30 tablets
Active ingredients: Pyridostigmine bromide
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PYRIDOSTIGMINE PHARMACIE CENTRALE DES ARMEES 30 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium polyamide PVC de 30 comprimé(s) en étui carton
- Marketing authorisation holder
- PHARMACIE CENTRALE DES ARMEES- PCA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 18 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63281870CIP75505541CIP133400955055419Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMURE DE PYRIDOSTIGMINEcomprimé | 30,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.